Item 2.02. |
Results of Operations and Financial Condition. |
Pharmacyclics, Inc - Recent Material EventOn
October 29, 2009, Pharmacyclics, Inc., a Delaware corporation (the
“Registrant”), issued a press release regarding its financial results for its
first quarter of fiscal 2010. A copy of the press release is attached as Exhibit
99.1.
The
foregoing description is qualified in its entirety by reference to the
Registrant’s Press Release dated October 29, 2009, a copy of which is attached
hereto as Exhibit 99.1 and incorporated herein by reference.
The
information in this Current Report on Form 8-K, including the exhibit hereto,
shall not be deemed to be “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to
the liabilities thereof, nor shall it be deemed to be incorporated by reference
into future filings by the Company under the Exchange Act or under the
Securities Act of 1933, as amended, except to the extent specifically provided
in any such filing.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
EXHIBIT
INDEX
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||